ExPharma Limited is an company focussed on R&D and investment. We are a small but agile and highly focused team of senior individuals, with established networks and track records of entrepreneurial and investment success. We thrive on challenge and continually seek inventive solutions for both our own and clients projects. Our expertise and experience within R&D, CMC, regulatory affairs and business transactions ensures success and makes us the ideal partner to bring your concept to market.

Spanning a range of sectors within health and wellness, our activities cover food supplements, foods for special medical purposes, medical devices and diagnostics and our networks extend to pharmaceutical and nutrition companies, universities and investors.

We are fully aware of what it takes to develop innovative products and build competitive companies, offering perceptive support to new and existing management teams to bring companies and projects to realisation.

Our current activities include;

  • R&D for our internal portfolio of products
  • Scouting and Evaluation for Venture Capital and Private Equity Groups
  • Scouting for Pharma and Nutrition Companies
  • Pre-IP Opportunity Evaluation
  • Start-Up Business Support
  • Equity Investment

At ExPharma we combine our years of experience to look at projects through fresh eyes and provide guidance on the safest and fastest route to market from a regulatory and commercial standpoint.

Our Team

Experience through fresh eyes.

Danilo Casadei Massari

Danilo has extensive experience as a senior pharmaceutical executive and as a highly successful serial entrepreneur. Most recently he was a founder and President of CM&D Pharma Ltd, a medical foods company he founded in 2007 and sold to Nestle Health Science in 2011. He is currently a Director on the boards of two companies in the USA (Prismic Pharmaceuticals Inc. and Clinical Information Network Inc.) where he is a founding member, and one in Italy (Difass International Srl). Danilo is an expert in start-ups and co-ventures in the pharmaceutical sector.

Profile | LinkedIn

Marco Cartolari

Marco is an entrepreneur with over 25 years of managerial experience in a range of industries, including healthcare and financial services. The Ex-CEO of a pharmaceutical company in Europe, Marco currently advises, invests in and serves on the board of a variety of start-up businesses. In addition, he also actively consults with various companies on business strategy and development, partnership and market entry strategy and planning.

Profile | LinkedIn

Cristina Comelli

Cristina is passionate about the relationship between epigenetics and nutrition and the role that specific nutrients could exert in primary, and particularly in secondary, prevention of chronic diseases as functional adjuncts to medicinal products. Cristina has held senior R&D management positions in a number of European companies, is an inventor on numerous patents and often consults on regulatory affairs.

Profile | LinkedIn

Paolo Rampazzo

Paolo is an organic chemist by training but has held a wide range of operational responsibilities over his thirty years in the pharmaceutical industry. In two spells at Zambon Chimica, he served as Head of Quality Control and in-between, as Head of QC Chemical Laboratories at Fidia Farmaceutici. In addition he has been Head of Development and Operations  in further companies and served on Scientific Boards.

Profile | LinkedIn